Combined Drug Targeting of p53-dependent and -independent Pathways Depletes Myelofibrosis Hematopoietic Stem/Progenitor Cells.
Leukemia
; 36(3): 733-745, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34642468
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Pyrimidines
/
Hematopoietic Stem Cells
/
Tumor Suppressor Protein p53
/
Imidazolines
/
Primary Myelofibrosis
/
Imidazoles
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom